DRG International, Inc.
United Statesfrom the FDA registration address FDA establishment FEI 2245285
DRG International, Inc. is a medical device manufacturer, with 212 devices listed in FDA GUDID (FDA Class I and II) and 9 FDA recalls as of 21 Nov 2026.
- Devices
- 212
- Registrations
- FDA
- FDA recalls
- 96 ongoing
Registry facts
- Registries
- FDA GUDID 212
- Device classes
- FDA Class I 106
- FDA Class II 106
- FDA recalls
- Identifiers
- FDA FEI 2245285
What DRG International, Inc. makes
DRG International, Inc. manufactures in vitro diagnostic (IVD) enzyme immunoassay (EIA) kits for serum and plasma testing, including assays for thyroid markers (such as free thyroxine, free triiodothyronine, and thyroid antibodies), estradiol, luteinizing hormone, rheumatoid factor, anticardiolipin antibodies, and extractable nuclear antigens (ENA). Additional products cover vitamin D, Bordetella pertussis, Taenia Solium, varicella zoster virus, and testosterone measurements via ELISA formats.
The company’s portfolio includes devices classified as Class I and Class II under FDA regulations, all listed in the FDA’s Unique Device Identifier (UDI) database.
Catalogue
Search and filter all 212 devicesShowing 1-50 of 212
Company details
- FDA FEI number
- 2245285
- Address
- 841 Mountain Ave, Springfield, NJ, 07081
FDA recalls
FDA recall records list 9 recalls initiated by DRG International, Inc., the earliest on 2009-11-09 and the most recent on 2026-07-02. By recorded status: 6 ongoing and 3 terminated. The reasons filed fall into these groups: labeling or instructions for use, performance or accuracy and manufacturing or quality process. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
Recalls initiated per year
- 2017 0
- 2018 0
- 2019 0
- 2020 0
- 2021 2
- 2022 0
- 2023 0
- 2024 3
- 2025 1
- 2026 1
2026
- 2 Jul 2026 Z-0082-2027 Class II Ongoing Potential for false negative patient results.
Full distribution text
- 2 Jul 2026 Z-0082-2027 Class II Ongoing Potential for false negative patient results.
2025
- 4 Jun 2025 Z-2265-2025 Class III Ongoing An incoming complaint reported that the expiration date on the kit box label and Certificate of Analysis (CoA) exceeded the shelf life of the standards and control solutions in the kit by 2 months (i.e., 2026-03-31 instead of 2026-01-31). The expiration dates on the bottle labels were correct (i.e., 2026-01-31).
2024
- 7 Oct 2024 Z-0921-2025 Class II Ongoing The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.
- 13 Sep 2024 Z-0258-2025 Class III Ongoing The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk.
Full distribution text
- 5 Jul 2024 Z-2622-2024 Class III Ongoing Invalid Controls. The Low Control is out of range; too high which causes invalid runs that would result in repeating the runs and delays for reporting results to patients.
2021
- 21 Dec 2021 Z-0896-2022 Class II Terminated ODs of the standards too low(< 0.6 ODmax) may cause invalid runs, delayed patient results are possible
- 18 Oct 2021 Z-0310-2022 Class II Ongoing Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a delay in diagnosis and a consumption of patient samples.
2009
- 9 Nov 2009 Z-1067-2010 Unclassified (pre-2012) Terminated CHROMagar Products are labeled incorrectly. Label currently states that the product is for IVD use, when it should state that the product is intended For Research Use, Not for use in diagnostic procedures.
- 9 Nov 2009 Z-1068-2010 Unclassified (pre-2012) Terminated CHROMagar Products are labeled incorrectly. Label currently states that the product is for IVD use, when it should state that the product is intended For Research Use, Not for use in diagnostic procedures.
Frequently asked questions
How many devices does DRG International, Inc. have in the registry?
The registry currently lists 212 devices for DRG International, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list DRG International, Inc.'s devices?
Among its 50 most recently registered devices, DRG International, Inc. has devices listed in FDA GUDID (50 devices).
What risk classes do DRG International, Inc.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for DRG International, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
Are there FDA recall records for DRG International, Inc.?
FDA recall records list 9 recalls initiated by DRG International, Inc., the most recent initiated on 2 Jul 2026. 6 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from DRG International, Inc. in the registry?
The most recently registered devices listed for DRG International, Inc. include 25 OH Vitamin D Total (90') ELISA EIA-6087, Bordetella pertussis IgG ELISA EIA-3450, Anti-dsDNA IgM ELISA EIA-3564 and Free Thyroxine (fT4) ELISA EIA-4266.